A BCL6/BCOR/SIRT1 Complex Triggers Neurogenesis and Suppresses Medulloblastoma by Repressing Sonic Hedgehog Signaling

Cancer Cell

Volumn 26, Issue 6, 2014, Pages 797-812

  Tiberi, Luca ^a   Bonnefont, JérÔme ^a   vandenAmeele, Jelle ^a   LeBon, Serge Daniel ^a   Herpoel, Adèle ^a   Bilheu, Angéline ^a   Baron, Beverly W ^b   Vanderhaeghen, Pierre ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCOR PROTEIN; CASPASE 3; PROTEIN; PROTEIN BCL 6; SIRTUIN 1; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2; UNCLASSIFIED DRUG; BCL6 PROTEIN, HUMAN; BCOR PROTEIN, HUMAN; DNA BINDING PROTEIN; GLI PROTEIN; KRUPPEL LIKE FACTOR; ONCOPROTEIN; REPRESSOR PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MEDULLOBLASTOMA; MOUSE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CEREBELLUM; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE;

ERINACEIDAE; MUS;

ANIMALS; CELL LINE, TUMOR; CEREBELLUM; DNA-BINDING PROTEINS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MEDULLOBLASTOMA; MICE; MICE, TRANSGENIC; NEUROGENESIS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SIRTUIN 1; TRANS-ACTIVATORS;

EID: 84919479487     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2014.10.021     Document Type: Article

References (66)

1. Alvarez-Rodríguez R., Pons S. Expression of the proneural gene encoding Mash1 suppresses MYCN mitotic activity. J.Cell Sci. 2009, 122:595-599.
2. Asselin-Labat M.L., Sutherland K.D., Barker H., Thomas R., Shackleton M., Forrest N.C., Hartley L., Robb L., Grosveld F.G., van der Wees J., et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 2007, 9:201-209.
3. Baron B.W., Anastasi J., Montag A., Huo D., Baron R.M., Karrison T., Thirman M.J., Subudhi S.K., Chin R.K., Felsher D.W., et al. The human BCL6 transgene promotes the development of lymphomas in the mouse. Proc. Natl. Acad. Sci. USA 2004, 101:14198-14203.
4. Basso K., Dalla-Favera R. Roles of BCL6 in normal and transformed germinal center B cells. Immunol. Rev. 2012, 247:172-183.
5. Batlle E., Bacani J., Begthel H., Jonkheer S., Gregorieff A., van de Born M., Malats N., Sancho E., Boon E., Pawson T., et al. EphB receptor activity suppresses colorectal cancer progression. Nature 2005, 435:1126-1130.
6. Ben-Arie N., Bellen H.J., Armstrong D.L., McCall A.E., Gordadze P.R., Guo Q., Matzuk M.M., Zoghbi H.Y. Math1 is essential for genesis of cerebellar granule neurons. Nature 1997, 390:169-172.
7. Bossuyt W., Kazanjian A., De Geest N., Van Kelst S., De Hertogh G., Geboes K., Boivin G.P., Luciani J., Fuks F., Chuah M., et al. Atonal homolog 1 is a tumor suppressor gene. PLoS Biol. 2009, 7:e39.
8. Cerchietti L.C., Polo J.M., Da Silva G.F., Farinha P., Shaknovich R., Gascoyne R.D., Dowdy S.F., Melnick A. Sequential transcription factor targeting for diffuse large B-cell lymphomas. Cancer Res. 2008, 68:3361-3369.
9. Chang C.C., Ye B.H., Chaganti R.S., Dalla-Favera R. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. USA 1996, 93:6947-6952.
10. Cho J.H., Tsai M.J. Preferential posterior cerebellum defect in BETA2/NeuroD1 knockout mice is the result of differential expression of BETA2/NeuroD1 along anterior-posterior axis. Dev. Biol. 2006, 290:125-138.
11. Corrales J.D., Blaess S., Mahoney E.M., Joyner A.L. The level of sonic hedgehog signaling regulates the complexity of cerebellar foliation. Development 2006, 133:1811-1821.
12. Dahmane N., Ruiz i Altaba A. Sonic hedgehog regulates the growth and patterning of the cerebellum. Development 1999, 126:3089-3100.
13. Duy C., Hurtz C., Shojaee S., Cerchietti L., Geng H., Swaminathan S., Klemm L., Kweon S.M., Nahar R., Braig M., et al. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. Nature 2011, 473:384-388.
14. Emmenegger B.A., Hwang E.I., Moore C., Markant S.L., Brun S.N., Dutton J.W., Read T.A., Fogarty M.P., Singh A.R., Durden D.L., et al. Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastoma. Oncogene 2013, 32:4181-4188.
15. Flora A., Klisch T.J., Schuster G., Zoghbi H.Y. Deletion of Atoh1 disrupts Sonic Hedgehog signaling in the developing cerebellum and prevents medulloblastoma. Science 2009, 326:1424-1427.
16. Fuccillo M., Joyner A.L., Fishell G. Morphogen to mitogen: the multiple roles of hedgehog signalling in vertebrate neural development. Nat. Rev. Neurosci. 2006, 7:772-783.
17. Gilbertson R.J., Ellison D.W. The origins of medulloblastoma subtypes. Annu. Rev. Pathol. 2008, 3:341-365.
18. Grimmer M.R., Weiss W.A. BMPs oppose Math1 in cerebellar development and in medulloblastoma. Genes Dev. 2008, 22:693-699.
19. Hatzi K., Melnick A. Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis. Trends Mol. Med. 2014, 20:343-352.
20. Hochedlinger K., Yamada Y., Beard C., Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 2005, 121:465-477.
21. Hurtz C., Hatzi K., Cerchietti L., Braig M., Park E., Kim Y.M., Herzog S., Ramezani-Rad P., Jumaa H., Müller M.C., et al. BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia. J.Exp. Med. 2011, 208:2163-2174.
22. Huynh K.D., Bardwell V.J. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene 1998, 17:2473-2484.
23. Huynh K.D., Fischle W., Verdin E., Bardwell V.J. BCoR, a novel corepressor involved in BCL-6 repression. Genes Dev. 2000, 14:1810-1823.
24. Jeong J., Mao J., Tenzen T., Kottmann A.H., McMahon A.P. Hedgehog signaling in the neural crest cells regulates the patterning and growth of facial primordia. Genes Dev. 2004, 18:937-951.
25. Jones D.T., Jäger N., Kool M., Zichner T., Hutter B., Sultan M., Cho Y.J., Pugh T.J., Hovestadt V., Stütz A.M., et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 2012, 488:100-105.
26. Julian E., Dave R.K., Robson J.P., Hallahan A.R., Wainwright B.J. Canonical Notch signaling is not required for the growth of Hedgehog pathway-induced medulloblastoma. Oncogene 2010, 29:3465-3476.
27. Kaji T., Ishige A., Hikida M., Taka J., Hijikata A., Kubo M., Nagashima T., Takahashi Y., Kurosaki T., Okada M., et al. Distinct cellular pathways select germline-encoded and somatically mutated antibodies into immunological memory. J.Exp. Med. 2012, 209:2079-2097.
28. Kho A.T., Zhao Q., Cai Z., Butte A.J., Kim J.Y., Pomeroy S.L., Rowitch D.H., Kohane I.S. Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev. 2004, 18:629-640.
29. Kool M., Jones D.T., Jäger N., Northcott P.A., Pugh T.J., Hovestadt V., Piro R.M., Esparza L.A., Markant S.L., Remke M., et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 2014, 25:393-405. ICGC PedBrain Tumor Project.
30. Kouros-Mehr H., Bechis S.K., Slorach E.M., Littlepage L.E., Egeblad M., Ewald A.J., Pai S.Y., Ho I.C., Werb Z. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 2008, 13:141-152.
31. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
32. Machold R., Fishell G. Math1 is expressed in temporally discrete pools of cerebellar rhombic-lip neural progenitors. Neuron 2005, 48:17-24.
33. Maeda T., Hobbs R.M., Merghoub T., Guernah I., Zelent A., Cordon-Cardo C., Teruya-Feldstein J., Pandolfi P.P. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 2005, 433:278-285.
34. Marino S., Vooijs M., van Der Gulden H., Jonkers J., Berns A. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 2000, 14:994-1004.
35. Min S.W., Cho S.H., Zhou Y., Schroeder S., Haroutunian V., Seeley W.W., Huang E.J., Shen Y., Masliah E., Mukherjee C., et al. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron 2010, 67:953-966.
36. Nahar R., Ramezani-Rad P., Mossner M., Duy C., Cerchietti L., Geng H., Dovat S., Jumaa H., Ye B.H., Melnick A., Müschen M. Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood 2011, 118:4174-4178.
37. Ng J.M., Curran T. The Hedgehog's tale: developing strategies for targeting cancer. Nat. Rev. Cancer 2011, 11:493-501.
38. Northcott P.A., Jones D.T., Kool M., Robinson G.W., Gilbertson R.J., Cho Y.J., Pomeroy S.L., Korshunov A., Lichter P., Taylor M.D., Pfister S.M. Medulloblastomics: the end of the beginning. Nat. Rev. Cancer 2012, 12:818-834.
39. Northcott P.A., Korshunov A., Pfister S.M., Taylor M.D. The clinical implications of medulloblastoma subgroups. Nat Rev Neurol 2012, 8:340-351.
40. Olson J.M. Therapeutic opportunities for medulloblastoma come of age. Cancer Cell 2014, 25:267-269.
41. Parsons D.W., Li M., Zhang X., Jones S., Leary R.J., Lin J.C., Boca S.M., Carter H., Samayoa J., Bettegowda C., et al. The genetic landscape of the childhood cancer medulloblastoma. Science 2011, 331:435-439.
42. Phan R.T., Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004, 432:635-639.
43. Pugh T.J., Weeraratne S.D., Archer T.C., Pomeranz Krummel D.A., Auclair D., Bochicchio J., Carneiro M.O., Carter S.L., Cibulskis K., Erlich R.L., et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 2012, 488:106-110.
44. Radtke F., Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor?. Nat. Rev. Cancer 2003, 3:756-767.
45. Ranuncolo S.M., Polo J.M., Dierov J., Singer M., Kuo T., Greally J., Green R., Carroll M., Melnick A. Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat. Immunol. 2007, 8:705-714.
46. Robinson G., Parker M., Kranenburg T.A., Lu C., Chen X., Ding L., Phoenix T.N., Hedlund E., Wei L., Zhu X., et al. Novel mutations target distinct subgroups of medulloblastoma. Nature 2012, 488:43-48.
47. Romer J.T., Kimura H., Magdaleno S., Sasai K., Fuller C., Baines H., Connelly M., Stewart C.F., Gould S., Rubin L.L., Curran T. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 2004, 6:229-240.
48. Rose M.F., Ren J., Ahmad K.A., Chao H.T., Klisch T.J., Flora A., Greer J.J., Zoghbi H.Y. Math1 is essential for the development of hindbrain neurons critical for perinatal breathing. Neuron 2009, 64:341-354.
49. Roussel M.F., Hatten M.E. Cerebellum development and medulloblastoma. Curr. Top. Dev. Biol. 2011, 94:235-282.
50. Rudin C.M., Hann C.L., Laterra J., Yauch R.L., Callahan C.A., Fu L., Holcomb T., Stinson J., Gould S.E., Coleman B., et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N.Engl. J. Med. 2009, 361:1173-1178.
51. Sakano D., Kato A., Parikh N., McKnight K., Terry D., Stefanovic B., Kato Y. BCL6 canalizes Notch-dependent transcription, excluding Mastermind-like1 from selected target genes during left-right patterning. Dev. Cell 2010, 18:450-462.
52. Santoro F., Botrugno O.A., Dal Zuffo R., Pallavicini I., Matthews G.M., Cluse L., Barozzi I., Senese S., Fornasari L., Moretti S., et al. A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance. Blood 2013, 121:3459-3468.
53. Schüller U., Kho A.T., Zhao Q., Ma Q., Rowitch D.H. Cerebellar 'transcriptome' reveals cell-type and stage-specific expression during postnatal development and tumorigenesis. Mol. Cell. Neurosci. 2006, 33:247-259.
54. Schüller U., Heine V.M., Mao J., Kho A.T., Dillon A.K., Han Y.G., Huillard E., Sun T., Ligon A.H., Qian Y., et al. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 2008, 14:123-134.
55. Snuderl M., Batista A., Kirkpatrick N.D., Ruiz de Almodovar C., Riedemann L., Walsh E.C., Anolik R., Huang Y., Martin J.D., Kamoun W., et al. Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma. Cell 2013, 152:1065-1076.
56. Swaminathan S., Huang C., Geng H., Chen Z., Harvey R., Kang H., Ng C., Titz B., Hurtz C., Sadiyah M.F., et al. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint. Nat. Med. 2013, 19:1014-1022.
57. Taipale J., Beachy P.A. The Hedgehog and Wnt signalling pathways in cancer. Nature 2001, 411:349-354.
58. Thompson M.C., Fuller C., Hogg T.L., Dalton J., Finkelstein D., Lau C.C., Chintagumpala M., Adesina A., Ashley D.M., Kellie S.J., et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J.Clin. Oncol. 2006, 24:1924-1931.
59. Tiberi L., van den Ameele J., Dimidschstein J., Piccirilli J., Gall D., Herpoel A., Bilheu A., Bonnefont J., Iacovino M., Kyba M., et al. BCL6 controls neurogenesis through Sirt1-dependent epigenetic repression of selective Notch targets. Nat. Neurosci. 2012, 15:1627-1635.
60. Wang X., Venugopal C., Manoranjan B., McFarlane N., O'Farrell E., Nolte S., Gunnarsson T., Hollenberg R., Kwiecien J., Northcott P., et al. Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells. Oncogene 2012, 31:187-199.
61. Wang G., Lunardi A., Zhang J., Chen Z., Ala U., Webster K.A., Tay Y., Gonzalez-Billalabeitia E., Egia A., Shaffer D.R., et al. Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion. Nat. Genet. 2013, 45:739-746.
62. Wetmore C., Eberhart D.E., Curran T. Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. Cancer Res. 2001, 61:513-516.
63. Yang Z.J., Ellis T., Markant S.L., Read T.A., Kessler J.D., Bourboulas M., Schüller U., Machold R., Fishell G., Rowitch D.H., et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 2008, 14:135-145.
64. Ye B.H., Lista F., Lo Coco F., Knowles D.M., Offit K., Chaganti R.S., Dalla-Favera R. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science 1993, 262:747-750.
65. Ye B.H., Cattoretti G., Shen Q., Zhang J., Hawe N., de Waard R., Leung C., Nouri-Shirazi M., Orazi A., Chaganti R.S., et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 1997, 16:161-170.
66. Zhao H., Ayrault O., Zindy F., Kim J.H., Roussel M.F. Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development. Genes Dev. 2008, 22:722-727.